Fosun Acquires 75% of Vaccine Maker Aleph Biomedical

Fosun Pharmaceutical has bought a 75% stake in Dalian Aleph Biomedical, a vaccine maker, at a price reported as 675 million RMB ($102.4 million). Established in 2002, Aleph’s main product is an inactivated split flu vaccine. More details....
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.